HIGHLIGHTS
- who: Gregorio Romero-Gonzu00e1lez et al. from the Nephrology Department, University Hospital Germans Trias i Pujol (HGiTP), Badalona, Spain have published the paper: The u201cFIFTY SHADOWSu201d of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease, in the Journal: (JOURNAL)
- what: Globally, 850 million people have CKD, and it is projected that by 2040, it will be the fifth leading cause of death in the world [66].
- how: The trial was conducted in 600 villages in rural China with at least 35 participants per . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.